Clinical Trials Browser

Phase 2/3 × Uterine Cervical Neoplasms × Brachytherapy × Clear all

NCT06288373 2024-10-30

Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC

Phase 2/3 Recruiting

Uterine Cervical Neoplasms